Back to Search
Start Over
Preimplantation genetic screening in older women: a cost-effectiveness analysis
- Source :
- Fertility and Sterility. 90:592-598
- Publication Year :
- 2008
- Publisher :
- Elsevier BV, 2008.
-
Abstract
- Objective To compare the strategy of traditional IVF with prenatal diagnosis versus IVF with preimplantation genetic screening (IVF/PGS) to prevent aneuploid births in women with advanced maternal age. Design A decision tree analytic model was created to compare IVF alone versus IVF/PGS to evaluate which strategy is the least costly per healthy (euploid) infant. Setting Outpatient IVF practices. Patient(s) Infertile women, 38–40 and >40 years old. Intervention(s) IVF or IVF/PGS. Main Outcome Measure(s) Cost per healthy infant. Result(s) Using base-case estimates of costs and probabilities in women aged 38–40 years, after a maximum of two fresh IVF cycles and two frozen cycles, the chance of having a healthy infant was 37.8% with IVF alone versus 21.7% with IVF/PGS. The average cost for each strategy is $25,700, but the cost per healthy infant is substantially higher when IVF/PGS is applied as opposed to IVF alone ($118,713 vs. $68,026). To assess the robustness of the model, all probabilities were varied simultaneously in a Monte Carlo simulation, and in 96.2% of trials, IVF alone proved to be the most cost-effective option. Conversely, our data demonstrate that in women aged >40, IVF and IVF/PGS are essentially equal in terms of cost-effectiveness ($122,000 vs. $118,713). Conclusion(s) IVF alone is less costly per healthy infant than IVF/PGS in women ages 38–40.
- Subjects :
- Adult
medicine.medical_specialty
Cost-Benefit Analysis
Genetic Counseling
Prenatal diagnosis
Age Distribution
Pregnancy
Humans
Medicine
Genetic Testing
Advanced maternal age
Preimplantation Diagnosis
reproductive and urinary physiology
Gynecology
urogenital system
business.industry
Medical screening
Analytic model
Outcome measures
Obstetrics and Gynecology
Health economy
Cost-effectiveness analysis
United States
female genital diseases and pregnancy complications
Treatment Outcome
Reproductive Medicine
embryonic structures
Cost analysis
Women's Health
Female
business
Infertility, Female
Live Birth
hormones, hormone substitutes, and hormone antagonists
Subjects
Details
- ISSN :
- 00150282
- Volume :
- 90
- Database :
- OpenAIRE
- Journal :
- Fertility and Sterility
- Accession number :
- edsair.doi.dedup.....c4364d68a66b9de8f5fc8f8593b2b608